Prescriptions: F.D.A. Rejects New Diabetes Drug
Tuesday, October 19, 2010 - 21:30
in Health & Medicine
The F.D.A. asked Eli Lilly & Company and Amylin Pharmaceuticals to conduct a study to test for possible cardiac effects of the drug, Bydureon.